{"id":"https://openalex.org/W2004016685","doi":"https://doi.org/10.1111/j.1365-2125.2001.01303.x","title":"Nasal retention of budesonide and fluticasone in man: Formation of airway mucosal budesonide-esters in vivo","display_name":"Nasal retention of budesonide and fluticasone in man: Formation of airway mucosal budesonide-esters in vivo","publication_year":2001,"publication_date":"2001-02-01","ids":{"openalex":"https://openalex.org/W2004016685","doi":"https://doi.org/10.1111/j.1365-2125.2001.01303.x","mag":"2004016685","pmid":"https://pubmed.ncbi.nlm.nih.gov/11259988","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2014447"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2125.2001.01303.x","doi":"https://doi.org/10.1111/j.1365-2125.2001.01303.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2001.01303.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2001.01303.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2001.01303.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091661205","display_name":"Hannes Petersen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hannes Petersen,","raw_affiliation_strings":["Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, Reykjavik, Iceland,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, Reykjavik, Iceland,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036474371","display_name":"Annika Kullberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Annika Kullberg,","raw_affiliation_strings":["Department of Experimental Medicine, AstraZeneca R & D, Lund, University Hospital, Lund, Sweden,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Medicine, AstraZeneca R & D, Lund, University Hospital, Lund, Sweden,","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111826482","display_name":"Staffan Edsb\u00e4cker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]},{"id":"https://openalex.org/I4210137844","display_name":"Sk\u00e5ne University Hospital","ror":"https://ror.org/02z31g829","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210137844"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Staffan Edsbacker,","raw_affiliation_strings":["Department of Clinical Pharmacology, University Hospital, Lund, Sweden,","Department of Experimental Medicine, AstraZeneca R & D, Lund, University Hospital, Lund, Sweden,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University Hospital, Lund, Sweden,","institution_ids":["https://openalex.org/I4210137844"]},{"raw_affiliation_string":"Department of Experimental Medicine, AstraZeneca R & D, Lund, University Hospital, Lund, Sweden,","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065809036","display_name":"Lennart Greiff","orcid":"https://orcid.org/0000-0002-7004-1989","observed_orcids":["https://orcid.org/0000-0002-7004-1989"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lennart Greiff","raw_affiliation_strings":["Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, Lund, Sweden","institution_ids":["https://openalex.org/I187531555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":3.1421,"has_fulltext":true,"cited_by_count":37,"citation_normalized_percentile":{"value":0.90956296,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"51","issue":"2","first_page":"159","last_page":"163"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.7914999723434448,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.7914999723434448,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.15729999542236328,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10984","display_name":"Sinusitis and nasal conditions","score":0.020400000736117363,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluticasone-propionate","display_name":"fluticasone propionate","score":1.0},{"id":"https://openalex.org/keywords/nasal-mucosa","display_name":"nasal mucosa","score":0.6859999895095825},{"id":"https://openalex.org/keywords/drug-survival","display_name":"drug retention","score":0.765999972820282},{"id":"https://openalex.org/keywords/topical-glucocorticosteroids","display_name":"topical glucocorticosteroids","score":0.9070000052452087},{"id":"https://openalex.org/keywords/nasal-biopsy","display_name":"nasal biopsy","score":0.6439999938011169},{"id":"https://openalex.org/keywords/tissue-drug-concentration","display_name":"tissue drug concentration","score":0.4320000112056732},{"id":"https://openalex.org/keywords/rhinitis","display_name":"rhinitis","score":0.7419999837875366},{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/lipophilicity","display_name":"lipophilicity","score":0.6169999837875366},{"id":"https://openalex.org/keywords/intranasal-drug-delivery","display_name":"intranasal drug delivery","score":0.34700000286102295}],"concepts":[{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.9683313369750977},{"id":"https://openalex.org/C2779028295","wikidata":"https://www.wikidata.org/wiki/Q8564098","display_name":"Fluticasone propionate","level":3,"score":0.8801739811897278},{"id":"https://openalex.org/C2781212218","wikidata":"https://www.wikidata.org/wiki/Q1002165","display_name":"Fluticasone","level":3,"score":0.7470254302024841},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5366283059120178},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4943549633026123},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.47717347741127014},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4673369824886322},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38215675950050354},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34002748131752014}],"mesh":[{"descriptor_ui":"D000068298","descriptor_name":"Fluticasone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000730","descriptor_name":"Androstadienes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009297","descriptor_name":"Nasal Mucosa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019819","descriptor_name":"Budesonide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019819","descriptor_name":"Budesonide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1111/j.1365-2125.2001.01303.x","doi":"https://doi.org/10.1111/j.1365-2125.2001.01303.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2001.01303.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2001.01303.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"doi:10.1046/j.1365-2125.2001.01303.x","doi":"https://doi.org/10.1046/j.1365-2125.2001.01303.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.2001.01303.x","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2014447","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2014447","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:11259988","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11259988","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Clinical Trial"},{"id":"pmh:oai:www.hirsla.lsh.is:2336/119829","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2336/119829","pdf_url":null,"source":{"id":"https://openalex.org/S4306401083","display_name":"Hirsla (Landsp\u00edtali University Hospital)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210106610","host_organization_name":"National University Hospital of Iceland","host_organization_lineage":["https://openalex.org/I4210106610"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2125.2001.01303.x","doi":"https://doi.org/10.1111/j.1365-2125.2001.01303.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.2001.01303.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2001.01303.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320321806","display_name":"Lunds Universitet","ror":"https://ror.org/012a77v79"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2004016685.pdf","grobid_xml":"https://content.openalex.org/works/W2004016685.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1524870590","https://openalex.org/W1555822229","https://openalex.org/W1994954312","https://openalex.org/W2090555292","https://openalex.org/W2101742307","https://openalex.org/W2126810972","https://openalex.org/W2147251547","https://openalex.org/W2155345300","https://openalex.org/W2172582324","https://openalex.org/W2183913543"],"related_works":["https://openalex.org/W2052967220","https://openalex.org/W2101742307","https://openalex.org/W2147251547","https://openalex.org/W1992040251","https://openalex.org/W2114218759","https://openalex.org/W1964177272","https://openalex.org/W2064764547","https://openalex.org/W2092483414","https://openalex.org/W2091161061","https://openalex.org/W2047153325"],"abstract_inverted_index":{"AIMS:":[0],"The":[1,57,171,224,257,293],"efficacy":[2],"of":[3,59,70,78,102,105,173,193,228,244,288,299,330,336,343],"topical":[4,106],"glucocorticosteroids":[5],"in":[6,17,48,82,167,198,214,284,301,306,313,345],"rhinitis":[7],"and":[8,72,75,110,119,132,143,149,154,159,178,209,220,232,237,253,269,279,286,308,332],"asthma":[9],"is":[10,311,325],"likely":[11],"to":[12,43,64,317,339],"depend":[13],"on":[14,183],"drug":[15,100,164],"retention":[16,24,69,101,342],"the":[18,49,54,60,66,76,83,88,120,194,215,241,289,297,302,314,328,346],"airway":[19,50,347],"mucosa.":[20,85,348],"With":[21],"fluticasone":[22,73,111,179,210,245,280,322],"propionate,":[23,74],"may":[25,37],"be":[26,38],"achieved":[27],"exclusively":[28],"by":[29,40],"lipophilicity,":[30],"whereas":[31],"for":[32],"budesonide":[33,71,107,229,278,310,337,344],"an":[34,340],"additional":[35],"possibility":[36],"provided":[39],"its":[41],"ability":[42],"form":[44],"fatty":[45],"acid":[46],"esters":[47],"mucosa":[51,305,316],"that":[52,309,327],"release":[53,335],"active":[55],"drug.":[56],"aim":[58],"present":[61,89,294],"study":[62,295],"was":[63,123,181,196],"determine":[65],"nasal":[67,84,98,134,304,315],"mucosal":[68,99],"occurrence":[77],"budesonide-esters":[79,300,331],"(budesonide-oleate,":[80],"budesonide-palmitate)":[81],"METHODS:":[86],"In":[87],"study,":[90],"involving":[91],"24":[92,155,161,276],"healthy":[93],"subjects,":[94,222],"we":[95],"have":[96],"examined":[97],"single":[103],"doses":[104],"(256":[108],"microg)":[109],"propionate":[112,180,211,246,260,281],"(200":[113],"microg).":[114],"Treatments":[115],"were":[116,126,136,212,235,251,264,282],"given":[117],"consecutively":[118],"administration":[121],"sequence":[122],"randomised.":[124],"Subjects":[125],"randomised":[127],"into":[128],"four":[129],"parallel":[130],"groups":[131],"two":[133],"biopsies":[135],"taken":[137,200],"from":[138,217],"each":[139],"subject,":[140],"i.e.":[141],"before":[142,158,201],"at":[144,147,152,160,230,247],"2":[145,148,231],"h,":[146,151,156,277],"6":[150,153,233],"or":[157],"h":[162,234],"after":[163],"administration,":[165,205],"resulting":[166],"12":[168],"biopsies/time":[169],"point.":[170],"measurement":[172],"unesterified":[174,206],"budesonide,":[175,207],"budesonide-oleate,":[176],"budesonide-palmitate,":[177],"based":[182],"microwave":[184],"extraction":[185],"procedures":[186],"combined":[187],"with":[188],"liquid-chromatography/tandem":[189],"mass-spectrometry.":[190],"RESULTS:":[191],"Neither":[192],"analytes":[195],"detected":[197,213,283],"samples":[199],"glucocorticosteroid":[202],"administration.":[203],"After":[204],"budesonide-esters,":[208],"tissue":[216,226,261],"23,":[218],"20,":[219],"19":[221],"respectively.":[223,274,291],"mean":[225,242],"levels":[227,243],"1051":[236],"176":[238],"pmol":[239,255],"g(-1);":[240],"these":[248],"time":[249],"points":[250],"237":[252],"10":[254],"g(-1).":[256],"dose-corrected":[258],"budesonide/fluticasone":[259],"concentration":[262],"ratios":[263],"3.5":[265],"(P":[266,271],"=":[267],"0.07)":[268],"13.7":[270],"<":[272],"0.0002),":[273],"At":[275],"8/12":[285],"3/12":[287],"biopsies,":[290],"CONCLUSIONS:":[292],"demonstrates":[296],"formation":[298,329],"human":[303],"vivo,":[307],"retained":[312],"a":[318],"greater":[319],"extent":[320],"than":[321],"propionate.":[323],"It":[324],"suggested":[326],"their":[333],"subsequent":[334],"contributes":[338],"extended":[341]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}